This illustrates the challenges that diligent physicians have in keeping up with new developments in their field.
Yesterday, I posted on the side effects of immunotherapy treatment for cancer.
Today, we have an article from researchers at UPenn on the use of an existing drug (a class of drugs known as JAK inhibitors) to reduce the risk of these side effects.
Some doctors use combinations of immunotherapy drugs to assure effectiveness against the target cancer. However, the combinations seem to increase the risk of major side effects.
Use of the JAK inhibitor with a single immunotherapy drug can be as effective as use of the combination of drugs, without the increased risk of side effects.
Each day, there’s something new. Is your doctor keeping up with his homework?
That’s the major reason you always need second opinions for anything important.
- “Disabling critical ‘node’ revs up attack when cancer immunotherapies fall short”, Science Daily, 1 December 2016 (published 5 December). https://www.sciencedaily.com/releases/2016/12/161201164457.htm